Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1995-6-21
|
| pubmed:abstractText |
This brief report is a preliminary review of the interpretation of 'final height' in a large study of children, some of whom have been treated with recombinant human growth hormone for as long as 8 years. Most of the children in this study have not attained final height, so we highlight the issues relating to the definition of final height, study completion and diagnosis.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0301-0163
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
43
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
129-31
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7750912-Adolescent,
pubmed-meshheading:7750912-Body Height,
pubmed-meshheading:7750912-Bone Development,
pubmed-meshheading:7750912-Child,
pubmed-meshheading:7750912-Female,
pubmed-meshheading:7750912-Growth Hormone,
pubmed-meshheading:7750912-Humans,
pubmed-meshheading:7750912-Male
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Approaching final height in children treated for growth hormone deficiency.
|
| pubmed:affiliation |
Division of Diabetes Care and Endocrinology, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|